Effectiveness Study of a Dialectical Behavioral Treatment for Families of Adolescents With Emotional Instability (FAL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02991586|
Recruitment Status : Recruiting
First Posted : December 13, 2016
Last Update Posted : December 13, 2016
Emotional instability disorder (IE) is appreciable since adolescence, and crises (suicidal ideation, self-harm, impulsive acts and brief psychotic episodes) carry a high use of health resources, coupled with the suffering of families who feel helpless and difficulties in handling.
The purpose of the study is to evaluate the effectiveness of a dialectical behavior therapy (DBT) for parents of adolescents with IE who are in treatment in the different network devices of Child and Adolescent Mental Health of the Community of Madrid. Treatment goals are the development of communication skills, validation and crisis management as well as increase understanding and competence of the pathology.
To evaluate the effectiveness of the DBT family group intervention, it is compared with a group of non-treatment or "treatment as usual" (outpatient treatment and parents without children specific group treatment). The DBT intervention will begin with two individual sessions with parents of patients and 10 theoretical and practical seminars in group format (6-7 families) following the model proposed by Marsha Linehan. The DBT interventions will be added to "standard treatment" that a patient with IE receives in the investigative devices.
The result of these interventions will be measured after the end of treatment and after 6 and 12 months after the treatment ends. The variables considered are family communication, cognitive skills, emotional and behavioral coping clinical in parents and as indirect measures of change in adolescents health resources used as , suicidal gestures, self-harm or aggressive behavior.
|Condition or disease||Intervention/treatment||Phase|
|Emotional Instability||Behavioral: Dialectical Behaviour Therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Effectiveness Study of a Dialectical Behavioral Treatment for Families of Adolescents With Emotional Instability|
|Study Start Date :||May 2016|
|Estimated Primary Completion Date :||May 2018|
|Estimated Study Completion Date :||December 2020|
Experimental: Dialectical Behavior Therapy
Dialectical Behavior Therapy (DBT) is a cognitive behavioral treatment that was originally developed to treat chronically suicidal individuals diagnosed with borderline personality disorder (BPD) and it is now recognized as the gold standard psychological treatment for this population. In addition, research has shown that it is effective in treating a wide range of other disorders such as substance dependence, depression, post-traumatic stress disorder (PTSD), and eating disorders. In this research DBT skills will be taught to parents of adolescents with high emotional instability
Behavioral: Dialectical Behaviour Therapy
Group of families
No Intervention: Control
Control: The "No intervention arm" in this research is defined as follow:, sons and daughters are in their respective treatment but parents are nor receiving any DBT intervention
- Difficulties in Emotional Regulation Scale (DERS). (Hervás 2008) [ Time Frame: one year ]
- Automatic Anger and Hostility Thoughts Scale (IPRI) (Magán 2010) [ Time Frame: one year ]
- Coping Styles and Strategies Scale (COPE) (Crespo 1997) [ Time Frame: one year ]
- Children Relapses and Self harms Questionnaire (Ad Hoc) [ Time Frame: one year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02991586
|Contact: Maria Mayoral, PhD||+34 firstname.lastname@example.org|
|Instituto Provincial de Psiquiatria, Hospital General Universitario Gregorio Maranon. Calle Ibiza 43||Recruiting|
|Madrid, Spain, 28009|
|Contact: Maria Mayoral, PhD 914265005 email@example.com|
|Principal Investigator:||Maria Mayoral, PhD||Gregorio Marañon Hospital|